BridgeMed Health
Outcomes Report, December 2025
Results & Outcomes

What the data shows

Source: BridgeMed Health Claims Gains data, December 2025. Based on 595+ referrals since June 2023.

Outcomes at a glance

86%
Return to Work or Off-Benefits
66%
Change in diagnosis after FPA
98%
Medication change following FPA
57%
Workplace issues identified

Return-to-work outcomes

86% of cases closed with a return to work or off-benefits outcome.

  • 67% returned to work.
  • 19% closed off-benefits or in a gradual return to work (GRTW).
  • 14% closed on-benefits for medical or other reasons.

Median disability duration at referral was 5.4 months (164 days).

Medication review

In 98% of cases, the FPA identified a medication change that was clinically warranted.

Manulife reported that members tested in its Personalized Medicine program had spent an average of 14 months on medication therapy before testing. BridgeMed reviews medication as part of the FPA.

Sources: BridgeMed Health Claims Gains data, December 2025. Manulife Personalized Medicine program data, 2018–2020, published in 2022.

What People Say

From plan members.

The Psychiatrist I met was very kind and helpful. It was amazing to have an appointment with a Specialist so fast, and then meet a Therapist through the same program who helped me Return to Work.
Plan Member
My therapist was amazing. She helped me understand many different ways to cope with my issues. She was so sensitive and supportive.
Plan Member

Ready to send your first referral?

FPA appointment within 10 business days. Function-focused report delivered to GP and case manager.